Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, and sell of pharmaceutical products in the People’s Republic o...
Extrawell Pharmaceutical relocates Bermuda registered office to Richmond House, Hamilton HM 08
Extrawell Pharma announces shareholder meeting
Extrawell Pharmaceutical publishes 2026 annual report
Artini swings to FY26 net loss of HK$9.63 million; revenue rises 7.6% to HK$162.12 million
Starcoin postpones shareholder meeting on HK$715 million convertible bond restructuring until September 2026
Extrawell Pharma expects at least HK$950 million loss for FY2026, swings from profit